Recent developments in dry powder inhalation (DPI) formulations for lung-targeted drug delivery
Background Dry powder inhalation (DPI) formulations have been widely studied for the
treatment of respiratory diseases, including COVID-19, which have become common and …
treatment of respiratory diseases, including COVID-19, which have become common and …
gene expression in the heart left ventricle as a response to the various durations of the intensive exercise: An experimental study
F Sheikhzadeh, N Khajehnasiri… - Endocrine …, 2024 - sciendo.com
Objective. Myocardial fibrosis is a devastating condition causing millions of deaths yearly.
Several factors, such as aging, cause myocardial fibrosis. The Wnt/β-catenin pathway is one …
Several factors, such as aging, cause myocardial fibrosis. The Wnt/β-catenin pathway is one …
No drug–drug interactions between selective prolyl‐tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants
W Shin, MY Park, J Kim, J Kim, JH Nam… - Clinical and …, 2024 - Wiley Online Library
Bersiporocin, a potent and selective prolyl‐tRNA synthetase inhibitor, is expected to show a
synergistic effect with pirfenidone or nintedanib in patients with idiopathic pulmonary …
synergistic effect with pirfenidone or nintedanib in patients with idiopathic pulmonary …